Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Pept Sci ; 29(4): e3459, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36274190

ABSTRACT

The helix-sense inversions of poly(ß-phenethyl l-aspartate) (2P) and diblock copolymers (2P-3P), with 2P and poly(ß-phenylpropyl l-aspartate) (3P) blocks, were studied in their solid states using synchrotron wide-angle X-ray diffraction and small-angle X-ray scattering. The characteristic parameters of the π-helix structure of 2P were directly determined in situ after the helix transition at a high temperature. In the 2P-3P block copolymers, the main chains of the 3P blocks initially convert from right- to left-handed α-helices, and then the 2P blocks convert irreversibly from right-handed α-helices to left-handed π-helices. The chemical structures of the side chains of poly(l-aspartic acid ester)s significantly affect their helix transition behaviors.


Subject(s)
Aspartic Acid , Peptides , Peptides/chemistry , X-Ray Diffraction , Synchrotrons , Polymers
2.
J Pept Sci ; 27(6): e3311, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33605058

ABSTRACT

The helix-sense reversal of poly(ß-phenylpropyl l-aspartate) (3PLA) in the solid state was studied by synchrotron wide-angle X-ray diffraction and small-angle X-ray scattering. The direct determination of the characteristic helical pitch before and after the transition revealed that the transition takes place reversibly between the two α-helices having opposite screw-sense during the heating and cooling cycle. While the hexagonal packing remains unaltered, the helix-sense inversion causes discontinuous changes in the molecular arrangement and, by extension, the crystalline dimension. In this study, another transition was detected at a higher temperature from the left-handed α-helix to the π-helix, the molecular chirality being unaffected.


Subject(s)
Aspartic Acid/chemistry , Polymers/chemistry , Aspartic Acid/chemical synthesis , Molecular Structure , Polymers/chemical synthesis , Synchrotrons , X-Ray Diffraction
3.
Eur J Immunol ; 44(6): 1747-58, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24723437

ABSTRACT

T cells express multiple integrin molecules. The significance of signaling through these molecules on acquisition of T-cell effector functions and memory formation capacity remains largely unknown. Moreover, the impact of stimulation through these signals on the generation of T cells for adoptive immunotherapy has not been elucidated. In this study, using a recombinant fragment of fibronectin, CH-296, we demonstrated that stimulation via very late Ag (VLA)-4 and VLA-5 in human and BALB/c mouse CD8(+) T cells, in combination with TCR stimulation, enhances effector multifunctionality and in vivo memory formation. Using TCR-transgenic mouse-derived CD8(+) T cells expressing TCR specific for the syngeneic CMS5 fibrosarcoma-derived tumor Ag, we showed that stimulation by CH-296 improved the ability of tumor-specific CD8(+) T cells to inhibit CMS5 tumor growth when adoptively transferred into hosts with progressing tumors. Improved antitumor effects were associated with decreased infiltration of Foxp3(+) CD4(+) Treg cells in tumors. These results suggest that stimulation via VLA-4 and VLA-5 modulates the qualities of effector T cells and could potentially increase the efficacy of adoptive therapy against cancer.


Subject(s)
Antigens, Neoplasm/immunology , Fibrosarcoma/immunology , Immunologic Memory , Integrin alpha4beta1/immunology , Integrin alpha5beta1/immunology , Adoptive Transfer , Animals , Antigens, Neoplasm/genetics , CD8-Positive T-Lymphocytes , Cell Line, Tumor , Female , Fibrosarcoma/genetics , Fibrosarcoma/pathology , Fibrosarcoma/therapy , Humans , Integrin alpha4beta1/genetics , Integrin alpha5beta1/genetics , Mice , Mice, Inbred BALB C , Mice, Transgenic , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/pathology
4.
Mol Microbiol ; 87(1): 66-79, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23216750

ABSTRACT

The liver stage is the first stage of the malaria parasite that replicates in the vertebrate host. However, little is known about the interplay between the parasite liver stage and its host cell, the hepatocyte. In this study, we identified an exported protein that has a critical role in parasite development in host hepatocytes. Expressed sequence tag analysis of Plasmodium berghei liver-stage parasites indicated that transcripts encoding a protein with an N-terminal signal peptide, designated liver-specific protein 2 (LISP2), are highly expressed in this stage. Expression of LISP2 was first observed 24 h after infection and rapidly increased during the liver-stage schizogony. Immunofluorescent staining with anti-LSP2 antibodies showed that LISP2 was carried to the parasitophorous vacuole and subsequently transported to the cytoplasm and nucleus of host hepatocytes. Gene targeting experiments demonstrated that majority of the LISP2-mutant liver-stage parasites arrested their development during formation of merozoites. These results indicate that exported LISP2 is involved in parasite-host interactions required for the development of liver-stage parasites inside hepatocytes. This study demonstrated that mid-to-late liver-stage malarial parasites have a system for exporting proteins to the host cell as intraerythrocytic stages do and presumably to use the proteins to modify the host cell and improve the environment.


Subject(s)
Hepatocytes/metabolism , Hepatocytes/parasitology , Merozoites/growth & development , Plasmodium berghei/growth & development , Plasmodium berghei/metabolism , Protozoan Proteins/metabolism , Cytoplasm/metabolism , Expressed Sequence Tags , Hepatocytes/cytology , Host-Parasite Interactions , Humans , Liver/parasitology , Malaria/parasitology , Merozoites/pathology , Plasmodium berghei/genetics , Plasmodium berghei/immunology , Promoter Regions, Genetic , Protein Sorting Signals/genetics , Protein Transport , Protozoan Proteins/genetics
5.
Exp Hematol ; 41(4): 367-76.e1, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23257689

ABSTRACT

T cell precursors are an attractive target for adoptive immunotherapy. We examined the regulation of human early T lymphopoiesis by human bone marrow stromal cells to explore in vitro manipulation of human T cell precursors in a human-only coculture system. The generation of CD7(+)CD56(-)cyCD3(-) proT cells from human hematopoietic progenitors on telomerized human bone marrow stromal cells was enhanced by stem cell factor, flt3 ligand, and thrombopoietin, but these stimulatory effects were suppressed by interleukin 3. Expression of Notch ligands Delta-1 and -4 on stromal cells additively promoted T cell differentiation into the CD7(+)cyCD3(+) pre-T cell stage, while cell growth was strongly inhibited. By combining these coculture systems, we found that initial coculture with telomerized stromal cells in the presence of stem cell factor, flt3 ligand, and thrombopoietin, followed by coculture on Delta-1- and -4-coexpressing stromal cells led to a higher percentage and number of pre-T cells. Adoptive immunotherapy using peripheral blood T cells transduced with a tumor antigen-specific T cell receptor (TCR) is a promising strategy but has several limitations, such as the risk of forming a chimeric TCR with the endogenous TCR. We demonstrated that incubation of TCR-transduced hematopoietic progenitors with the combination of coculture systems gave rise to CD7(+)TCR(+)CD3(+)CD1a(-) T cell precursors that rapidly proliferated and differentiated under the culture condition to induce mature T cell differentiation. These data show the regulatory mechanism of early T lymphopoiesis on human stromal cells and the potential utility of engineered human stromal cells to manipulate early T cell development for clinical application.


Subject(s)
Hematopoietic Stem Cells/cytology , Lymphopoiesis , Mesenchymal Stem Cells/cytology , T-Lymphocytes/cytology , Animals , Antigens, CD7/metabolism , Blotting, Western , CD3 Complex/metabolism , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Line , Cells, Cultured , Coculture Techniques , Flow Cytometry , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hematopoietic Stem Cells/metabolism , Humans , Immunotherapy, Adoptive/methods , Interleukin-3/pharmacology , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Membrane Proteins/pharmacology , Mesenchymal Stem Cells/metabolism , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/metabolism , Stem Cell Factor/pharmacology , T-Lymphocytes/metabolism , Telomere/genetics , Telomere/metabolism , Thrombopoietin/pharmacology , Time Factors
6.
Cell Microbiol ; 11(9): 1329-39, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19438514

ABSTRACT

Most Apicomplexa are obligatory intracellular parasites that multiply inside a so-called parasitophorous vacuole (PV) formed upon parasite entry into the host cell. Plasmodium, the agent of malaria and the Apicomplexa most deadly to humans, multiplies in both hepatocytes and erythrocytes in the mammalian host. Although much has been learned on how Apicomplexa parasites invade host cells inside a PV, little is known of how they rupture the PV membrane and egress host cells. Here, we characterize a Plasmodium protein, called LISP1 (liver-specific protein 1), which is specifically involved in parasite egress from hepatocytes. LISP1 is expressed late during parasite development inside hepatocytes and locates at the PV membrane. Intracellular parasites deficient in LISP1 develop into hepatic merozoites, which display normal infectivity to erythrocytes. However, LISP1-deficient liver-stage parasites do not rupture the membrane of the PV and remain trapped inside hepatocytes. LISP1 is the first Plasmodium protein shown by gene targeting to be involved in the lysis of the PV membrane.


Subject(s)
Liver/parasitology , Plasmodium berghei/physiology , Protozoan Proteins/physiology , Vacuoles/parasitology , Animals , Gene Deletion , Gene Expression Profiling , Gene Targeting , Molecular Sequence Data , Plasmodium berghei/genetics , Protozoan Proteins/genetics
7.
Cancer Res ; 68(14): 5948-54, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18632650

ABSTRACT

We previously found that a Salmonella typhimurium vector engineered to secrete soluble tumor antigen induces CD4(+) T cells resistant to CD4(+)CD25(+) regulatory T cells (Treg) and that glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) signal is involved in the development of this resistance. In this study, we address the potential of incorporating GITR ligand (GITRL) as a way to augment the immunogenicity of cancer vaccines. BALB/c mice were immunized by gene gun with plasmids encoding the mutated extracellular signal-regulated kinase 2 (mERK) with or without plasmids encoding mouse GITRL. Coadministration with GITRL during primary and secondary immunization enhanced the induction of mERK-specific CD8(+) T cells. Antibody depletion and minigene analysis suggested that GITRL directly activated CTL epitope-specific CD8(+) T cells independently of CD4(+) T cells. Immunization with plasmids encoding a CTL epitope and GITRL resulted in strong tumor inhibition in a CD8(+) T cell-dependent manner. Furthermore, CTL epitope-specific CD8(+) T cells induced by immunization with plasmids encoding CTL epitope coadministered with GITRL were refractory to suppression by CD4(+)CD25(+) Tregs compared with CD8(+) T cells induced without GITR signaling. We propose that coadministration of GITR signaling agents with tumor antigens constitutes a promising novel strategy for cancer vaccine development.


Subject(s)
CD8-Positive T-Lymphocytes/cytology , Glucocorticoids/metabolism , T-Lymphocytes, Regulatory/metabolism , Tumor Necrosis Factors/metabolism , Animals , CD8-Positive T-Lymphocytes/metabolism , Epitopes/chemistry , Female , Genetic Vectors , Interleukin-2 Receptor alpha Subunit/biosynthesis , Mice , Mice, Inbred BALB C , Mitogen-Activated Protein Kinase 1/metabolism , Models, Biological , Plasmids/metabolism , Signal Transduction
8.
FEBS J ; 274(16): 4271-86, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17645545

ABSTRACT

Two plasma kallikrein-kinin system inhibitors in the salivary glands of the kissing bug Triatoma infestans, designated triafestin-1 and triafestin-2, have been identified and characterized. Reconstitution experiments showed that triafestin-1 and triafestin-2 inhibit the activation of the kallikrein-kinin system by inhibiting the reciprocal activation of factor XII and prekallikrein, and subsequent release of bradykinin. Binding analyses showed that triafestin-1 and triafestin-2 specifically interact with factor XII and high molecular weight kininogen in a Zn2+-dependent manner, suggesting that they specifically recognize Zn2+-induced conformational changes in factor XII and high molecular weight kininogen. Triafestin-1 and triafestin-2 also inhibit factor XII and high molecular weight kininogen binding to negatively charged surfaces. Furthermore, they interact with both the N-terminus of factor XII and domain D5 of high molecular weight kininogen, which are the binding domains for biological activating surfaces. These results suggest that triafestin-1 and triafestin-2 inhibit activation of the kallikrein-kinin system by interfering with the association of factor XII and high molecular weight kininogen with biological activating surfaces, resulting in the inhibition of bradykinin release in an animal host during insect blood-feeding.


Subject(s)
Insect Proteins/genetics , Kallikrein-Kinin System/drug effects , Salivary Glands/metabolism , Salivary Proteins and Peptides/genetics , Triatoma/genetics , Amino Acid Sequence , Animals , Blood Coagulation/drug effects , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Factor XII/antagonists & inhibitors , Factor XII/chemistry , Factor XII/metabolism , Insect Proteins/metabolism , Insect Proteins/pharmacology , Kinetics , Kinins/antagonists & inhibitors , Kinins/blood , Molecular Sequence Data , Molecular Weight , Phylogeny , Plasma Kallikrein/antagonists & inhibitors , Prekallikrein/antagonists & inhibitors , Prekallikrein/chemistry , Prekallikrein/metabolism , Protein Binding/drug effects , Recombinant Proteins/chemistry , Recombinant Proteins/pharmacology , Salivary Proteins and Peptides/metabolism , Salivary Proteins and Peptides/pharmacology , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Triatoma/metabolism , Whole Blood Coagulation Time , Zinc/pharmacology
9.
Insect Biochem Mol Biol ; 37(5): 466-77, 2007 May.
Article in English | MEDLINE | ID: mdl-17456441

ABSTRACT

A new kallikrein-kinin system inhibitor, designated anophensin, was identified in the salivary glands of the malaria vector mosquito, Anopheles stephensi. In vitro reconstitution experiments showed that anophensin inhibits activation of the kallikrein-kinin system by inhibiting the reciprocal activation of factor XII (FXII) and prekallikrein (PK), and subsequent release of bradykinin. Additionally, anophensin inhibits activation of the kallikrein-kinin system on cultured human umbilical vein endothelial cells (HUVECs). Direct binding assays show that this inhibitory effect is due to Zn(2+)-dependent specific binding of anophensin to both FXII and high molecular weight kininogen (HK). Furthermore, anophensin interacts with both the N-terminus of FXII and domain D5 of HK, which are the binding domains for biological activating surfaces. These results suggest that anophensin inhibits activation of the kallikrein-kinin system by interfering with the association of FXII and HK with biological activating surfaces, resulting in the inhibition of bradykinin release in a host animal during insect blood-feeding.


Subject(s)
Anopheles/metabolism , Factor XII/antagonists & inhibitors , Insect Proteins/pharmacology , Insect Vectors/metabolism , Kallikrein-Kinin System/drug effects , Kininogen, High-Molecular-Weight/antagonists & inhibitors , Amino Acid Sequence , Animals , Binding Sites , Bradykinin/metabolism , Cells, Cultured , Cloning, Molecular , DNA, Complementary/chemistry , Factor XII/chemistry , Factor XII/metabolism , Humans , Insect Proteins/chemistry , Insect Proteins/metabolism , Kininogen, High-Molecular-Weight/chemistry , Kininogen, High-Molecular-Weight/metabolism , Molecular Sequence Data , Protein Structure, Tertiary , Salivary Glands/metabolism , Sequence Alignment , Zinc/metabolism
10.
FEBS J ; 273(13): 2955-62, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16759235

ABSTRACT

To facilitate feeding, certain hematophagous invertebrates possess inhibitors of collagen-induced platelet aggregation in their saliva. However, their mechanisms of action have not been fully elucidated. Here, we describe two major salivary proteins, triplatin-1 and -2, from the assassin bug, Triatoma infestans, which inhibited platelet aggregation induced by collagen but not by other agents including ADP, arachidonic acid, U46619 and thrombin. Furthermore, these triplatins also inhibited platelet aggregation induced by collagen-related peptide, a specific agonist of the major collagen-signaling receptor glycoprotein (GP)VI. Moreover, triplatin-1 inhibited Fc receptor gamma-chain phosphorylation induced by collagen, which is the first step of GPVI-mediated signaling. These results strongly suggest that triplatins target GPVI and inhibit signal transduction necessary for platelet activation by collagen. This is the first report on the mechanism of action of collagen-induced platelet aggregation inhibitors from hematophagus invertebrates.


Subject(s)
Collagen/chemistry , Platelet Aggregation Inhibitors/pharmacology , Salivary Proteins and Peptides/chemistry , Triatoma/metabolism , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid/pharmacology , Amino Acid Sequence , Animals , Arachidonic Acid/chemistry , Blood Platelets/metabolism , Cloning, Molecular , Molecular Sequence Data , Platelet Aggregation , Platelet Membrane Glycoproteins/chemistry , Saliva/metabolism , Salivary Proteins and Peptides/pharmacology , Signal Transduction
11.
Mol Microbiol ; 59(4): 1175-84, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16430692

ABSTRACT

Plasmodium parasites are fertilized in the mosquito midgut and develop into motile zygotes, called ookinetes, which invade the midgut epithelium. Here we show that a calcium-dependent protein kinase, CDPK3, of the rodent malarial parasite (Plasmodium berghei) is produced in the ookinete stage and has a critical role in parasite transmission to the mosquito vector. Targeted disruption of the CDPK3 gene decreased ookinete ability to infect the mosquito midgut by nearly two orders of magnitude. Electron microscopic analyses demonstrated that the disruptant ookinetes could not access midgut epithelial cells by traversing the layer covering the cell surface. An in vitro migration assay showed that these ookinetes lack the ability to migrate through an artificial gel, suggesting that this defect caused their failure to access the epithelium. In vitro migration assays also suggested that this motility is induced in the wild type by mobilization of intracellular stored calcium. These results indicate that a signalling pathway involving calcium and CDPK3 regulates ookinete penetration of the layer covering the midgut epithelium. Because humans do not possess CDPK family proteins, CDPK3 is a good target for blocking malarial transmission to the mosquito vector.


Subject(s)
Culicidae/parasitology , Malaria/parasitology , Oocysts/pathogenicity , Plasmodium berghei/pathogenicity , Protein Kinases/metabolism , Protozoan Proteins/metabolism , Animals , Cell Movement/genetics , Collagen/metabolism , Culicidae/cytology , Drug Combinations , Epithelial Cells/parasitology , Female , Genes, Protozoan , Laminin/metabolism , Mice , Mice, Inbred BALB C , Oocysts/enzymology , Plasmodium berghei/enzymology , Protein Kinases/genetics , Proteoglycans/metabolism , Protozoan Proteins/genetics , Rats , Rats, Wistar , Sequence Deletion
12.
J Biol Chem ; 277(31): 27651-8, 2002 Aug 02.
Article in English | MEDLINE | ID: mdl-12011093

ABSTRACT

The salivary glands of female mosquitoes contain a variety of bioactive substances that assist their blood-feeding behavior. Here, we report a salivary protein of the malarial vector mosquito, Anopheles stephensi, that inhibits activation of the plasma contact system. This factor, named hamadarin, is a 16-kDa protein and a major component of the saliva of this mosquito. Assays using human plasma showed that hamadarin dose-dependently inhibits activation of the plasma contact system and subsequent release of bradykinin, a primary mediator of inflammatory reactions. Reconstitution experiments showed that hamadarin inhibits activation of the plasma contact system by inhibition of the reciprocal activation of factor XII and kallikrein. Direct binding assays demonstrated that this inhibitory effect is due to hamadarin binding to both factor XII and high molecular weight kininogen and interference in their association with the activating surface. The assays also showed that hamadarin binding to these proteins depends on Zn(2+) ions, suggesting that hamadarin binds to these contact factors by recognizing their conformational change induced by Zn(2+) binding. We propose that hamadarin may attenuate the host's acute inflammatory responses to the mosquito's bites by inhibition of bradykinin release and thus enable mosquitoes to take a blood meal efficiently and safely.


Subject(s)
Anopheles/physiology , Factor XII/antagonists & inhibitors , Insect Proteins/pharmacology , Kininogen, High-Molecular-Weight/metabolism , Recombinant Proteins/pharmacology , Salivary Proteins and Peptides/pharmacology , Animals , Factor XII/metabolism , Female , Humans , Kallikreins/antagonists & inhibitors , Kinetics , Molecular Sequence Data , Salivary Proteins and Peptides/genetics , Time Factors , Zinc/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...